The private equity market will likely drive IPO volumes higher than 2024, but the strength of the PE market could cap the ...

Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the United States, ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Guangdong Hongshi Laser Technology Co., Ltd. (HSG Laser) has failed to complete its initial public offering (IPO), marking a ...

End of the customary 25-day period after an IPO during which the major analyst firms who have been involved in the IPO do not publish research on the company. Lockup Exp.

CX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red ...

“For example, to cover a territory of over 10,000 ... According to a recent market research report by MarketsAndMarkets, the global software defined radio wireless broadband industry is expected ...

The midpoint of the expected IPO price range would give Smithfield ... We also reference original research from other reputable publishers where appropriate. You can learn more about the standards ...

IPO Watch: Veeda Clinical Research has refiled its draft prospectus for an IPO with SEBI, seeking to raise ₹185 crore. (Image: Pixabay) IPO Watch: Veeda Clinical Research has refiled its draft ...

Beyond using AI to draft IPO prospectuses to court potential ... and cutting down on redundancies in the equity-research example would be "a massive process change." "It's hard, because people ...